Finanzwire Finanzwire
Basculer en Français
10651 Companies
226542 Keywords
155028 Articles
119935 Press releases
Headlines Articles Press releases Meril Life Sciences Remove
  1. Home
  2. Companies
  3. Meril Life Sciences
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/21/2025 at 11:15, 7 months 5 days ago

    Meril Life Sciences Unveils One-Year Results from LANDMARK Trial

    Clinical Outcomes Meril Life Sciences LANDMARK Trial Myval THV Aortic Stenosis
  • PRESS RELEASE

    published on 11/21/2025 at 11:10, 7 months 5 days ago

    Meril Life Sciences Presents One-year Outcomes from the LANDMARK Randomized Controlled Trial at PCR London Valves 2025

    Meril Life Sciences presents one-year outcomes from the LANDMARK Randomized Controlled Trial at PCR London Valves 2025, comparing THV series in aortic stenosis patients. Study highlights Myval THV series performance in clinical efficacy and patient safety
    Meril Life Sciences LANDMARK Trial Aortic Stenosis PCR London Valves 2025 THV Series
    Logo of Meril Life Sciences
Accesswire
  • Published on 06/27/2026 at 01:40, 4 hours 16 minutes ago

    Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting

  • Published on 06/27/2026 at 00:00, 5 hours 56 minutes ago

    Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010

  • Published on 06/26/2026 at 23:00, 6 hours 56 minutes ago

    Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting

  • Published on 06/26/2026 at 22:50, 7 hours 6 minutes ago

    Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada

  • Published on 06/26/2026 at 22:15, 7 hours 41 minutes ago

    Revive Therapeutics Announces Proposed Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 06/27/2026 at 00:05, 5 hours 51 minutes ago

    EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

  • Published on 06/27/2026 at 00:04, 5 hours 52 minutes ago

    Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering

  • Published on 06/26/2026 at 23:36, 6 hours 20 minutes ago

    Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering

  • Published on 06/26/2026 at 23:36, 6 hours 20 minutes ago

    EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share

  • Published on 06/26/2026 at 23:27, 6 hours 28 minutes ago

    EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE

View all EQS
Les Echos
  • Published on 06/26/2026 at 17:45, 12 hours 11 minutes ago

    Combined General Meeting, June 25, 2026

  • Published on 06/26/2026 at 14:44, 15 hours 11 minutes ago

    Safran information

  • Published on 06/26/2026 at 07:00, 22 hours 56 minutes ago

    Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel

  • Published on 06/25/2026 at 17:50, 1 day 12 hours ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 06/25/2026 at 07:30, 1 day 22 hours ago

    Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy